The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation

References

• Alenezi F, Fudim M, Rymer J, Dunning A, Chiswell K, Swaminathan M, Bottiger B, Velagapudi P, Nicoara A, Kisslo J, et al. 2019. Predictors and changes in cardiac hemodynamics and geometry with transcatheter aortic valve implantation. Am J Cardiol. 123(5):813–819. doi: 10.1016/j.amjcard.2018.11.038
   PubMed Web of Science ®Google Scholar
• Arsalan M, Weferling M, Hecker F, Filardo G, Kim W-K, Pollock BD, Van Linden A, Arsalan-Werner A, Renker M, Doss M, et al. 2018. TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model. EuroIntervention. 13(13):1520–1526. doi: 10.4244/EIJ-D-17-00421
   PubMed Web of Science ®Google Scholar
• Baldenhofer G, Zhang K, Spethmann S, Laule M, Eilers B, Leonhardt F, Sanad W, Dreger H, Sander M, Grubitzsch H, et al. 2014. Galectin-3 predicts short- and long-term outcome in patients undergoing transcatheter aortic valve implantation (TAVI). Int J Cardiol. 177(3):912–917. doi: 10.1016/j.ijcard.2014.10.010
   PubMed Web of Science ®Google Scholar
• Barili F, Pacini D, Capo A, Rasovic O, Grossi C, Alamanni F, Di Bartolomeo R, Parolari A. 2013. Does EuroSCORE II perform better than its original versions? A multicentre validation study. Eur Heart J. 34(1):22–29. doi: 10.1093/eurheartj/ehs342
   PubMed Web of Science ®Google Scholar
• Debonnaire P, Fusini L, Wolterbeek R, Kamperidis V, van Rosendael P, van der Kley F, Katsanos S, Joyce E, Tamborini G, Muratori M, et al. 2015. Value of the "TAVI2-SCORe" versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 115(2):234–242. doi: 10.1016/j.amjcard.2014.10.029
   PubMed Web of Science ®Google Scholar
• Gomes B, Pilz M, Reich C, Leuschner F, Konstandin M, Katus HA, Meder B. 2021. Machine learning-based risk prediction of intrahospital clinical outcomes in patients undergoing TAVI. Clin Res Cardiol. 110(3):343–356. doi: 10.1007/s00392-020-01691-0
   PubMed Web of Science ®Google Scholar
• Grover FL, Vemulapalli S, Carroll JD, Edwards FH, Mack MJ, Thourani VH, Brindis RG, Shahian DM, Ruiz CE, Jacobs JP, et al. 2017. 2016 Annual report of the society of thoracic surgeons/American college of cardiology transcatheter valve therapy registry. J Am Coll Cardiol. 69(10):1215–1230. doi: 10.1016/j.jacc.2016.11.033
   PubMed Web of Science ®Google Scholar
• Holmes DR, Nishimura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH, Peterson ED, Rumsfeld JS, Shahian DM, Thourani VH, et al. 2015. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. J Am Coll Cardiol. 66(25):2813–2823. doi: 10.1016/j.jacc.2015.10.021
   PubMed Web of Science ®Google Scholar
• Kötting J, Schiller W, Beckmann A, Schäfer E, Döbler K, Hamm C, Veit C, Welz A. 2013. German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg. 43(5):971–977. doi: 10.1093/ejcts/ezt114
   PubMed Web of Science ®Google Scholar
• La Manna A, Sanfilippo A, Capodanno D, Salemi A, Cadoni A, Cascone I, Polizzi G, Figuera M, Pittalà R, Privitera C, et al. 2013. Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 15(1):39. doi: 10.1186/1532-429X-15-39
   PubMedGoogle Scholar
• Lindroos M, Kupari M, Heikkilä J, Tilvis R. 1993. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 21(5):1220–1225. doi: 10.1016/0735-1097(93)90249-z
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, et al. 2019. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 380(18):1695–1705. doi: 10.1056/NEJMoa1814052
   PubMed Web of Science ®Google Scholar
• Magalhaes MA, Koifman E, Torguson R, Minha S, Gai J, Kiramijyan S, Escarcega RO, Baker NC, Wang Z, Goldstein S, et al. 2015. Outcome of left-sided cardiac remodeling in severe aortic stenosis patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 116(4):595–603. doi: 10.1016/j.amjcard.2015.05.018
   PubMed Web of Science ®Google Scholar
• Mizutani K, Hara M, Iwata S, Murakami T, Shibata T, Yoshiyama M, Naganuma T, Yamanaka F, Higashimori A, Tada N, et al. 2017. Elevation of B-type natriuretic peptide at discharge is associated with 2-year mortality after transcatheter aortic valve replacement in patients with severe aortic stenosis: insights from a multicenter prospective OCEAN-TAVI (optimized transcatheter valvular intervention-transcatheter aortic valve implantation) registry. J Am Heart Assoc. 6(7):e006112. doi: 10.1161/JAHA.117.006112
   PubMed Web of Science ®Google Scholar
• Musa TA, Treibel TA, Vassiliou VS, Captur G, Singh A, Chin C, Dobson LE, Pica S, Loudon M, Malley T, et al. 2018. Myocardial scar and mortality in severe aortic stenosis. Circulation. 138(18):1935–1947. doi: 10.1161/CIRCULATIONAHA.117.032839
   PubMed Web of Science ®Google Scholar
• Nahm FS. 2022. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 75(1):25–36. doi: 10.4097/kja.21209
   PubMed Web of Science ®Google Scholar
• Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. 2012. EuroSCORE II. Eur J Cardiothorac Surg. 41(4):734–745. doi: 10.1093/ejcts/ezs043
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand S-LT, DeLong ER, Shewan CM, Dokholyan RS, et al. 2009. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2–isolated valve surgery. Ann Thorac Surg. 88(1):S23–S42. doi: 10.1016/j.athoracsur.2009.05.056
   PubMed Web of Science ®Google Scholar
• O’Sullivan CJ, Stortecky S, Heg D, Jüni P, Windecker S, Wenaweser P. 2015. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation. EuroIntervention. 10(10):e1-8–e8. doi: 10.4244/EIJV10I10A200
   PubMed Web of Science ®Google Scholar
• Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2021. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 143(5):e35–e71. doi: 10.1161/CIR.0000000000000932
   PubMed Web of Science ®Google Scholar
• Parenica J, Nemec P, Tomandl J, Ondrasek J, Pavkova-Goldbergova M, Tretina M, Jarkovsky J, Littnerova S, Poloczek M, Pokorny P, et al. 2012. Prognostic utility of biomarkers in predicting of one-year outcomes in patients with aortic stenosis treated with transcatheter or surgical aortic valve implantation. PLoS One. 7(12):e48851. doi: 10.1371/journal.pone.0048851
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, et al. 2019. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 380(18):1706–1715. doi: 10.1056/NEJMoa1816885
   PubMed Web of Science ®Google Scholar
• Puls M, Beuthner BE, Topci R, Vogelgesang A, Bleckmann A, Sitte M, Lange T, Backhaus SJ, Schuster A, Seidler T, et al. 2020. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis. Eur Heart J. 41(20):1903–1914. doi: 10.1093/eurheartj/ehaa033
   PubMed Web of Science ®Google Scholar
• Thornton GD, Musa TA, Rigolli M, Loudon M, Chin C, Pica S, Malley T, Foley JRJ, Vassiliou VS, Davies RH, et al. 2022. Association of myocardial fibrosis and stroke volume by cardiovascular magnetic resonance in patients with severe aortic stenosis with outcome after valve replacement: the British society of cardiovascular magnetic resonance AS700 study. JAMA Cardiol. 7(5):513–520. doi: 10.1001/jamacardio.2022.0340
   PubMed Web of Science ®Google Scholar
• Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, et al. 2022. 2021 ESC/EACTS guidelines for the management of valvular heart disease. EuroIntervention. 17(14):e1126–e1196. doi: 10.4244/EIJ-E-21-00009
   PubMed Web of Science ®Google Scholar
• Wolff G, Shamekhi J, Al-Kassou B, Tabata N, Parco C, Klein K, Maier O, Sedaghat A, Polzin A, Sugiura A, et al. 2021. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients. Clin Res Cardiol. 110(3):368–376. doi: 10.1007/s00392-020-01731-9
   PubMed Web of Science ®Google Scholar